U.S. Residential REITs Stock News

If you have been eyeing Kyndryl Holdings and wondering whether now is the right moment to buy, hold, or even reconsider your strategy, you are not alone. The company's stock has seen some dramatic swings lately, stirring up plenty of debate among investors trying to make sense of its momentum. Over the past year, Kyndryl’s stock is up more than 30%, which is impressive, especially when compared to some of its peers. However, shorter-term moves have been more volatile, with a 1-day gain of...

Here is the revised article text with em dashes removed and replaced with clearer formatting: If you have been following Navios Maritime Partners (NYSE:NMM), you probably noticed the latest earnings report paired with an update on its share buyback. The company posted second quarter sales of $327 million, down from the prior year, with net income stepping back as well. Following this softer performance, management revealed it completed a sizeable repurchase, retiring over 5% of its shares in...

Monolithic Power Systems (MPWR) has seen a fresh wave of attention after its stock dipped slightly, closing 0.7% lower yesterday. While there is no headline-making news or AI announcement fueling the move, any quick turn in share price tends to stir up questions, especially with how dynamic the semiconductor sector has felt lately. For investors on the fence, even modest drops in a quality name like this can feel like either a warning sign or a window of opportunity. Taking a broader view,...

Ceragon Networks ( NASDAQ:CRNT ) Second Quarter 2025 Results Key Financial Results Revenue: US$82.3m (down 14% from 2Q...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

ATRenew ( NYSE:RERE ) Second Quarter 2025 Results Key Financial Results Revenue: CN¥4.99b (up 32% from 2Q 2024). Net...

You may think that with a price-to-sales (or "P/S") ratio of 0.1x Taoping Inc. ( NASDAQ:TAOP ) is definitely a stock...

Let's talk about the popular Graco Inc. ( NYSE:GGG ). The company's shares had a relatively subdued couple of weeks in...

We wouldn't blame Alico, Inc. ( NASDAQ:ALCO ) shareholders if they were a little worried about the fact that Henry...

Graphic Packaging Holding Company's ( NYSE:GPK ) price-to-earnings (or "P/E") ratio of 12.7x might make it look like a...

Some Trustmark Corporation ( NASDAQ:TRMK ) shareholders may be a little concerned to see that the Chairman, Gerard...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

With a price-to-earnings (or "P/E") ratio of 49.3x Sonoco Products Company ( NYSE:SON ) may be sending very bearish...

Despite an already strong run, Gossamer Bio, Inc. ( NASDAQ:GOSS ) shares have been powering on, with a gain of 26% in...

The Cato Corporation ( NYSE:CATO ) shares have continued their recent momentum with a 25% gain in the last month alone...

TreeHouse Foods, Inc.'s ( NYSE:THS ) price-to-sales (or "P/S") ratio of 0.3x might make it look like a buy right now...

Ampco-Pittsburgh Corporation ( NYSE:AP ) shares have had a horrible month, losing 26% after a relatively good period...

Oklo (OKLO) recently gained notable attention by signing a memorandum of understanding with ABB to advance automation and safety at its digital monitoring room in Santa Clara, California. This strategic alliance could have supported the 68% increase in Oklo’s share price over the last quarter. The robust collaboration highlights a shift towards efficient nuclear power technology, a focus further emphasized by regulatory milestones with the U.S. Nuclear Regulatory Commission and ongoing...

IonQ (IONQ) made significant advancements in its intellectual property, adding new U.S. patents that strengthen its position in quantum computing. These developments focus on optimizing quantum circuits and long-distance quantum networking. Despite these strides, IonQ's stock fell 11% over the past week, aligning with a general downturn in the tech-heavy Nasdaq Composite, which also dropped, due to market-wide apprehension ahead of Federal Reserve Chair Jerome Powell's speech. The...

Aurora Innovation (AUR) recently announced its earnings for the second quarter and six months ended June 30, 2025, revealing sales of USD 1 million and a net loss of USD 201 million for the quarter. The company's stock experienced a 4% decline over the last quarter. During this time, Aurora was dropped from several growth-focused indices while being added to value-oriented ones, reflecting a shift in market perception. These changes, alongside broader market trends, such as a decline in...

Howmet Aerospace (HWM) is experiencing a period of transition as it navigates several recent developments, including the resignation of a key executive, Lola F. Lin, and the interim management changes set to occur in their Legal and Compliance teams. During the last quarter, the company's stock appreciated by 5%, a performance that comes amid increased market volatility with the broader market showing a mixed performance. Significant events, such as the company's strong earnings report,...

BlackSky Technology (BKSY) has gained attention with a substantial 52% rise in its share price over the last quarter, driven by significant client announcements and contract achievements. The company secured a pivotal Gen-2 space domain awareness expansion contract and an early access agreement for Gen-3 capabilities, highlighting the growing demand for its advanced imaging services. Additionally, a new U.S. Navy contract to develop optical inter-satellite link terminals further underscores...

Recursion Pharmaceuticals (RXRX) reported significant growth in sales and revenue for Q2 and the first half of 2025 but also experienced widening net losses. The release of their Boltz-2 model underscored a commitment to innovation, which resonates positively in a market focusing on technological advancements. Meanwhile, broader markets, including the S&P 500, faced a 1.5% decline, affected by investor caution ahead of Federal Reserve Chair Powell's speech. Within this market context, the...

AbbVie (ABBV) recently announced positive results from pivotal studies for its drug upadacitinib, which targeted severe alopecia areata, showcasing promising therapeutic advancements. Over the last quarter, AbbVie's share price increased by 15%, coinciding with broader product announcements and a strategic dividend declaration of $1.64 per share. Despite mixed earnings reports and market fluctuations, AbbVie's advances in product development and strategic expansions may have provided support...